Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POISE: Metoprolol in noncardiac surgery
NCT00182039Phase 3Terminated
- Sponsor
- Hamilton Health Sciences
- Start
- Oct 2002
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cardiovascular complications comparing Metoprolol with Placebo (2 arms). Primary endpoint: Major cardiovascular events (cardiovascular death, nonfatal myocardial infarction, or nonfatal cardiac arrest) at 30 days. Started Oct 2002; status: terminated.
02
Drugs
metoprolol
03
Conditions
cardiovascular complications
Beyond the preview
Go deeper on NCT00182039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182039.